AzTrials
AzTrials

AmputationNCT04725006

Sensory Responses to Dorsal Root Stimulation

An observational study of Amputation and Sensation, Phantom, run by Lee Fisher, PhD at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The goal of this project is to characterize the types of sensations that can be evoked via electrical stimulation of the spinal cord and spinal nerves. Patients will be recruited from a local pain clinic, each with a spinal cord stimulation device implanted, to participate in experiments to explore the ability to… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Amputation, Sensation, Phantom
What is being tested?
Spinal cord stimulation system
Type of treatment
Medical device
How many people
0 participants
Where
1 siteUnited States
Study dates
16 Dec 2020to 7 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Individuals undergoing a 7-day trial period of percutaneous DRG or spinal root stimulation.

Who may be able to join

  • Subjects must be between the ages of 18 and 70 years old.
  • Subjects must be undergoing an epidural spinal cord implanted electrode array clinical trial with Dr. Helm for the management of pain.
  • Persons must understand the consent and the procedures.

Who cannot join

  • Persons with open wounds;
  • Persons with implanted metal rods in the spine or limbs;
  • Persons with defibrillator or pacemaker;
  • Persons with permanent skin metal tags or decorations.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

The goal of this project is to characterize the types of sensations that can be evoked via electrical stimulation of the spinal cord and spinal nerves. Patients will be recruited from a local pain clinic, each with a spinal cord stimulation device implanted, to participate in experiments to explore the ability to modulate and control the modality, intensity, focality, and location of the sensations evoked by stimulation through the spinal cord stimulator leads. Investigators will connect spinal cord stimulator leads to a custom stimulator system and will ask subjects to report the types of sensations felt. Invesigators will also perform detailed psychophysical metrics to examine participants' ability to discriminate sensations.

Read the detailed description

For this study, investigators aim to determine whether DRG and spinal root stimulation might be viable techniques for restoring feedback. Investigators will focus on patients undergoing temporary percutaneous trials of DRG or lateral spinal cord stimulation with leads manufactured by either Boston Scientific (under PMA P030017) or St. Jude (under PMA P150004), which have FDA premarket approval for the management of chronic pain in the trunk and lower limbs. In this early experiment, investigators will not focus on individuals with limb loss, but rather will include patients already undergoing a percutaneous trial of DRG or spinal root stimulation to treat pain. Investigators will characterize the location, modality, and intensity of sensations evoked in the hands or feet with stimulation delivered by an external stimulator.

Being tested
Spinal cord stimulation system
Keywords
spinal cord stimulation, dorsal root ganglia stimulation, sensation, amputation, pain
Medical subject headings
Phantom Limb, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal cord stimulation systemDevice

    Also called Boston Scientific, St. Jude

    These systems are indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain and leg pain. Stimulation will be applied to the system using an external stimulator to see if sensations can be evoked in the participant's limb/foot.

Study groups in NCT04725006
Study groupRoleWhat they receive
Stimulation in individuals with implanted stimulation systemsDuring psychophysical stimulation trials, an external stimulator will be connected to the SCS lead, a volley of stimulation will be performed, and the subject will be asked to respond to standard psychophysical questions, as well as to provide any additional comments.
Receives: Device: Spinal cord stimulation system

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Location of evoked sensory percepts

    Document where on the body the subject perceives the stimulation locations.

    Measured: up to 2 days

  2. Stimulation perceptual thresholds to stimulus parameters

    Quantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.

    Measured: up to 2 days

  3. Stimulation neurophysiology thresholds to stimulus parameters

    Quantify the threshold stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation

    Measured: up to 2 days

Secondary outcomes (1)
  1. Qualitative self-report of evoked sensations

    Document the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device.

    Measured: up to 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2021
  2. Study start16 Dec 2020
  3. Primary completion11 Jul 2025
  4. Study completion7 Oct 2025

Why it stopped: No participant/patient opportunities for testing. Received funding for a different study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04725006
Sponsor's protocol ID
STUDY20020043
Status last verified
Oct 2025
First submitted
21 Jan 2021
Last updated
15 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation and Sensation, Phantom, run by Lee Fisher, PhD at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 15 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Location of evoked sensory percepts (time frame: up to 2 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in